{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,12]],"date-time":"2026-08-12T20:16:59Z","timestamp":1786565819943,"version":"build-2736575974"},"reference-count":14,"publisher":"Japanese Society of Internal Medicine","issue":"13","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2169\/internalmedicine.55.6330","type":"journal-article","created":{"date-parts":[[2016,6,30]],"date-time":"2016-06-30T23:02:50Z","timestamp":1467327770000},"page":"1779-1782","source":"Crossref","is-referenced-by-count":3,"title":["Pioglitazone-induced Pulmonary Injury in a Very Elderly Patient"],"prefix":"10.2169","volume":"55","author":[{"given":"Kohta","family":"Katayama","sequence":"first","affiliation":[{"name":"Division of General Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryo","family":"Kumagai","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoko","family":"Isono","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Fujihara","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yagyu","sequence":"additional","affiliation":[{"name":"Division of Endocrinology and Metabolism, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Ohara","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsunori","family":"Kagohashi","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Satoh","sequence":"additional","affiliation":[{"name":"Division of Respiratory Medicine, Mito Medical Center, University of Tsukuba-Mito Kyodo General Hospital, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Yki-J\u00e4rvinen H. Thiazolidinediones. N Engl J Med 351: 1106-1118, 2004.","DOI":"10.1056\/NEJMra041001"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Pershadsingh HA. Peroxisome proliferator-activated receptor-gamma: therapeutic target for diseases beyond diabetes: quo vadis? Expert Opin Investig Drugs 13: 215-228, 2004.","DOI":"10.1517\/13543784.13.3.215"},{"key":"3","doi-asserted-by":"publisher","unstructured":"3. Dormandy JA, Charbonnel B, Eckland DJ, et al. PROactive investigators. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial. Lancet 366: 1279-1289, 2005.","DOI":"10.1016\/S0140-6736(05)67528-9"},{"key":"4","unstructured":"4. Copper JA Jr. Drug-induced lung disease. Adv Intern Med 42: 231-268, 1997."},{"key":"5","doi-asserted-by":"publisher","unstructured":"5. Camus P, Fanton A, Bonniaud P, Camus C, Foucher P. Interstitial lung disease induced by drugs and radiation. Respiration 71: 301-326, 2004.","DOI":"10.1159\/000079633"},{"key":"6","doi-asserted-by":"publisher","unstructured":"6. Home PD, Pocock SJ, Beck-Nielsen H, et al. Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial. Lancet 373: 2125-2135, 2009.","DOI":"10.1016\/S0140-6736(09)60953-3"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Stone JC, Furuya-Kanamori L, Barendregt JJ, Doi SA. Was there really any evidence that rosiglitazone increased the risk of myocardial infarction or death from cardiovascular causes? Pharmacoepidemiol Drug Saf 24: 223-227, 2015.","DOI":"10.1002\/pds.3736"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Lu Y, Ma D, Xu W, Shao S, Yu X. Effect and cardiovascular safety of adding rosiglitazone to insulin therapy in type 2 diabetes: A meta-analysis. J Diabetes Investig 6: 78-86, 2015.","DOI":"10.1111\/jdi.12246"},{"key":"9","unstructured":"9. Chen X, Yang L, Zhai SD. Risk of cardiovascular disease and all-cause mortality among diabetic patients prescribed rosiglitazone or pioglitazone: a meta-analysis of retrospective cohort studies. Chin Med J (Engl) 125: 4301-4306, 2012."},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Korenstein D, Wisnivesky JP, Wyer P, Adler R, Ponieman D, McGinn T. The utility of B-type natriuretic peptide in the diagnosis of heart failure in the emergency department: a systematic review. BMC Emerg Med 7: 6, 2007.","DOI":"10.1186\/1471-227X-7-6"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Nakajima R, Sakai F, Mimura T, Tokuda H, Takahashi M, Kimura F. Acute- or subacute-onset lung complications in treating patients with rheumatoid arthritis. Can Assoc Radiol J 64: 200-207, 2013.","DOI":"10.1016\/j.carj.2011.12.017"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Papiris SA, Triantafillidou C, Kolilekas L, Markoulaki D, Manali ED. Amiodarone: review of pulmonary effects and toxicity. Drug Saf 33: 539-558, 2010.","DOI":"10.2165\/11532320-000000000-00000"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Matsuno O, Okubo T, Hiroshige S, et al. Drug-induced lymphocyte stimulation test is not useful for the diagnosis of drug-induced pneumonia. Tohoku J Exp Med 212: 49-53, 2007.","DOI":"10.1620\/tjem.212.49"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Kuhlman JE. The role of chest computed tomography in the diagnosis of drug-related reactions. J Thorac Imaging 6: 52-61, 1991.","DOI":"10.1097\/00005382-199101000-00008"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/13\/55_55.6330\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T17:33:39Z","timestamp":1498325619000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/55\/13\/55_55.6330\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":14,"journal-issue":{"issue":"13","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.55.6330","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}